Deoxyribonucleic Acid Trip
By Gina Maranto,
New York Times
| 08. 28. 2002
Book review of Gregory Stock,
Redesigning Humans: Our Inevitable
Genetic Future.
GREGORY STOCK has written an enthusiastic book in support of
germ-line manipulations -- that is, making genetic modifications
to eggs, sperm and embryos that can be passed on to future generations.
Like previous explorations of the subject by the ethicist Joseph
F. Fletcher, the lawyer John Robertson and the biologist James
Watson, among others, ''Redesigning Humans: Our Inevitable Genetic
Future'' serves as an apologia for those scientists and physicians
who are already edging toward such work in a piecemeal fashion
in research labs and in vitro fertilization clinics around the
world. It advocates the wholesale adoption of genetic manipulations
with the purpose of finally taking control of human evolution.
This, the author writes, ''is the ultimate expression and realization
of our humanity.''
Because of the breadth of his scientific knowledge and his
considerable flair as a writer, Stock -- who heads the program
on medicine, technology and society at the School of Medicine
of the University of California, Los Angeles -- is a forceful
advocate. First and foremost...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
